MESO FY 2007 Earnings — Mesoblast Limited Revenue & Financial Results | Market Cap Arena

MESOMesoblast Limited

$2B

FY 2007 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-40.5% YoY

Gross Profit

$2M100.0% margin

Operating Income

-$7M-417.6% margin

Net Income

-$9M-519.7% margin

EPS (Diluted)

$-0.16

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$547,850

Balance Sheet

Total Assets

$21M

Total Liabilities

$698,899

Stockholders' Equity

$21M

Cash & Equivalents

$12M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$3M	-40.5%
Gross Profit	$2M	$3M	-40.5%
Operating Income	-$7M	-$6M	-11.6%
Net Income	-$9M	-$8M	-5.2%